Expression of MAGE a 1-6 mRNA in sputa of head and neck cancer patients - A preliminary report

Anticancer Research

Volumn 26, Issue 2 B, 2006, Pages 1513-1518

  Lee, Kang Dae ^a,d   Lee, Hwan Ho ^a   Joo, Ho Bum ^a   Lee, Hyoung Shin ^a   Yu, Tai Hyun ^a   Chang, Hee Kyung ^a   Jeon, Chang Ho ^b   Park, Jong Wook ^c  

^a Kosin University   (South Korea)

^b Catholic University of Daegu   (South Korea)

^c Keimyung University   (South Korea)

^d NONE   (South Korea)

Author keywords

Head and neck cancer; MAGE gene; Sputum; Tumor marker

Indexed keywords

MELANOMA ANTIGEN; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 2; MELANOMA ANTIGEN 3; MELANOMA ANTIGEN 4; MELANOMA ANTIGEN 5; MELANOMA ANTIGEN 6; MESSENGER RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPUTUM; SQUAMOUS CELL CARCINOMA; TONGUE CANCER; TONSIL CANCER;

ADULT; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPUTUM; TUMOR MARKERS, BIOLOGICAL;

EID: 33645803227     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A and Boon T: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647, 1991.
2. Zammatteo N, Lockman L, Brasseur F, De Plaen E, Lurquin C, Lobert PE, Hamels S, Boon T and Remade J: DNA microarray to monitor the expression of MAGE-A genes. Clin Chem 48: 25-34, 2002.
3. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, van der Bruggen P, Lethe B and Lurquin C: Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40: 360-369, 1994.
4. Eura M, Ogi K, Chikamatsu K, Lee KD, Nakano K, Masuyama K, Itoh K and Ishikawa T: Expression of the MAGE gene family in human head-and-neck squamous-cell carcinomas. Int J Cancer 64: 304-308, 1995.
5. Lee KD, Eura M, Ogi K, Nakano K, Chikamatsu K, Masuyama K and Ishikawa T: Expression of the MAGE-1, -2, -3, -4, and -6 genes in non-squamous cell carcinoma lesions of the head and neck. ActaOtolaryngol 116: 633-639, 1996.
6. Lee KD, Chang HK, Jo YK, Kim BS, Lee BH, Lee YW, Lee HK, Huh MH, Min YG, Spagnoli GC and Yu TH: Expression of MAGE 3 gene product in squamous cell carcinomas of the head and neck. Anticancer Res 19: 5037-5042, 1999.
7. Inoue H, Li J, Honda M, Nakashima H, Shibuta K, Arinaga S, Ueo H, Mori M and Akiyoshi T: MAGE-1 mRNA expression in gastric carcinoma. Gastroenterol 109: 1522-1525, 1995.
8. Inoue H, Mori M, Li J, Mimori K, Honda M, Nakashima H, Mafune K, Tanaka Y and Akiyoshi T: Human esophageal carcinomas frequently express the tumor-rejection antigens of MAGE genes. Int J Cancer 63: 523-526, 1995.
9. Mori M, Inoue H, Mimori K, Shibuta K, Baba K, Nakashima H, Haraguchi M, Tsuji K, Ueo H, Barnard GF and Akiyoshi T: Expression of MAGE genes in human colorectal carcinoma. Ann Surg 224: 183-188, 1996.
10. Weynants P, Lethe B, Brasseur F, Marchand M and Boon T: Expression of MAGE genes by non-small cell lung carcinomas. Int J Cancer 56: 826-829, 1994.
11. Russo V, Traversari C, Verrecchia A, Mottolese M, Natali PG and Bordignon C: Expression of MAGE gene family in primary and metastatic human breast cancer: implications for tumor-specific immunotherapy. Int J Cancer 64: 216-221, 1995.
12. Russo V, Dalerba P, Ricci A, Bonazzi C, Leone BE, Mangioni C, Allavena P, Bordignon C and Traversari C: MAGE, BAGE and GAGE genes expression in fresh epithelial ovarian carcinomas. Int J Cancer 67: 457-460, 1996.
13. Yamashita N, Ishibashi H, Hayashida K, Kudo J, Takenaka K, Itoh K and Niho Y: High frequency of the MAGE-1 gene expression in hepatocellular carcinoma. Hepatology 24: 1437-1440, 1996.
14. Mori M, Mimori K, Tanaka F, Ueo H, Sugimachi K and Akiyoshi T: Molecular diagnosis of circulating cancer cells using MAGE gene assays. JAMA 278: 476-477, 1997.
15. Mou DC, Cai SL, Peng JR, Wang Y, Chen HS, Pang XW, Leng XS and Chen WF: Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells. Br J Cancer 86: 110-116, 2002.
16. Miyamoto A, Fujiwara Y, Sakon M, Nagano H, Sugita Y, Kondo M, Eguchi H, Dono K, Umeshita K, Nakamori S and Monden M: Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma. Dig Dis Sci 45: 1376-1382, 2000.
17. Park JW, Kwon TK, Kim IH, Sohn SS, Kim YS, Kim CI, Bae OS, Lee KS, Lee KD, Lee CS, Chang HK, Choe BK, Ahn SY and Jeon CH: A new strategy for the diagnosis of MAGE-expressing cancers. J Immunol Methods 266: 79-86, 2002.
18. Lee KD, Lee CS and Lee HH: Experimental studies on the significance of new MAGE common primers detecting MAGE 1-6 mRNA in head and neck cancers. Korean J Otolaryngol 44: 736-743, 2001.
19. Matsuda M, Nagumo S, Horai T and Yoshino K: Cytologic diagnosis of laryngeal and hypopharyngeal squamous cell carcinoma in sputum. Acta Cytol 32: 655-657, 1988.
20. Adamiak G, Ligezinski A, Jurkiewicz D, Hermanowski M, Konieczna M, Adamiak G, Ligezinski A, Jurkiewicz D, Hermanowski M and Konieczna M: Alpha-fetoprotein - diagnostic utility in squamous cell carcinoma of the head and neck. Pol Merkuriusz Lek 11: 320-322, 2001.
21. Rosati G, Riccardi F and Tucci A: Use of tumor markers in the management of head and neck cancer. Int J Biol Markers 15: 179-183, 2000.
22. Jang SJ, Soria JC, Wang L, Hassan KA, Morice RC, Walsh GL, Hong WK and Mao L: Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res 61: 7959-7963, 2001.